CASL - Canadian Association for the Study of the Liver

2025 Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective Conference
2025-10-25 - 2025-10-26 | Sheraton Centre Toronto Hotel, 123 Queen St W, Toronto, Ontario, Canada
The 2025 Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective Conference is a groundbreaking event hosted by the Ajmera Transplant Center in Toronto. The conference, scheduled for October 25-26, 2025, brings together international transplant leaders, clinicians, surgeons, nurses, researchers, policymakers, and representatives from academic and community-based organizations.
The conference aims to address the critical challenges faced by transplant providers and patients in achieving diversity, equity, and inclusion (DEI) across all organ groups. It emphasizes a patient-centric approach, ensuring that the voices and needs of patients and caregivers are central to the discussions. Attendees will have the opportunity to engage with notable speakers, explore DEI challenges, and contribute to a global dialogue on advancing DEI in transplantation.
This second edition will be co-located with the 6th Congress of International Advanced HBP Surgery (ISLS 2025) featuring a Joint Session with Keynote Speaker Dr. Nouman Ashraf addressing “Enabling Exemplary Care Through Behavioural Empathy.”
Attendees of the Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective Conference will receive a discount to attend ISLS 2025.
> LEARN MORE <

The 6th Congress of International Advanced HBP Surgery
2025-10-22 08:00 - 2025-10-25 17:00 UTC
The 6th Congress of International Advanced HBP Surgery will be held from October 22 to 25, 2025, at the Sheraton Centre Toronto Hotel in Canada. This prestigious event, organized by the International Society of Liver Surgeons (ISLS), brings together leading experts in hepatobiliary and pancreatic (HBP) surgery from around the world.

The congress will feature a diverse scientific program, including keynote lectures, free paper presentations, and interactive sessions. Attendees will have the opportunity to engage with cutting-edge research, innovative surgical techniques, and the latest advancements in HBP surgery. This biennial event is a must-attend for professionals seeking to enhance their knowledge and network with peers in the field.
For more details, visit the official ISLS Congress website

Educational Webinar Series: Introduction to Updated HBV Guidelines 2025
2025-10-09 19:30 - 21:00 (America/Toronto) | Online
Join us for the next session of CASL Educational Webinar Series: Introduction to Updated HBV Guidelines 2025 on Oct 9, 2025 07:30 PM Eastern Time (US and Canada).
> REGISTER NOW HERE

2025 CASL Single Topic Conference on Autoimmune and Rare Liver Disease
2025-10-06 - 2025-10-07 | Westin Bayshore Vancouver, 1601 Bayshore Dr, Vancouver, British Columbia, Canada
Join us at the 2025 CASL Single Topic Conference on Autoimmune and Rare Liver Disease, a premier event dedicated to advancing knowledge and collaboration in the field of liver health. This year’s conference, held in partnership with the CST Annual Scientific Meeting (CST ASM), offers a unique opportunity for delegates to benefit from a diverse range of research and insights.
Highlights:

Joint CASL & CST Liver Forum: Engage in networking and collaborative sessions with experts from both CASL and CST.
Cutting-edge Research: Discover the latest advancements in autoimmune and rare liver disease through presentations and discussions.
Expert Speakers: Learn from leading professionals in hepatology and related fields.
Networking Opportunities: Connect with peers and leaders in liver health to share knowledge and experiences.

Don’t miss this chance to be part of a dynamic and inspiring event in the beautiful city of Vancouver.
For more information, visit 2025 CASL Single Topic Conference on Autoimmune and Rare Liver Disease.

ISHEN 2025 Conference
2025-10-05 - 2025-10-08 | St-Alexis-des-Monts, St-Alexis-des-Monts, Canada
The International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) is excited to invite you to ISHEN 2025. Organized by Professor Christopher Rose and his team, the conference will take place from October 5-8, 2025, in the picturesque St-Alexis-des-Monts, Quebec, Canada.
This premier event will gather leading experts in the field to discuss the latest advancements in the pathophysiology, diagnosis, and treatment of hepatic encephalopathy. Attendees can look forward to a series of insightful presentations, workshops, and networking opportunities.

Inaugural Canadian Hepatitis B Patient Forum: Bringing Patients Together
2025-09-20 11:30 - 15:00 (America/Toronto) | Toronto, Toronto, Canada
Join us for the Inaugural Canadian Hepatitis B Patient Forum on September 20, 2025 — a free virtual event bringing together patients, caregivers, and experts to share experiences and learn about Hepatitis B.
11:30 AM – 3:00 PM ET | In-Person in Toronto & Vancouver Site only
️ Topics include treatment, patient journeys, liver cancer, and more.
Register now at canadianhbvnetwork.ca or chineseliversupportgroup.ca
️ Interpretation available in Cantonese, Mandarin, Vietnamese, and French.

CASL Annual General Meeting
2025-06-10 18:00 - 20:00 (America/Toronto) | Online
We look forward to welcoming you to the Canadian Association for the Study of the Liver (CASL) Annual General Meeting.
All CASL Members in good standing are invited to attend the AGM to learn about Association activities in the past year and provide input into future plans.
While the Annual General Meeting is open to everyone wishing to attend, only the eligible voting CASL members can vote on official motions.
Date:
Tuesday, June 10, 2025
Event Timing:
3:00pm VANCOUVER, Canada, British Columbia
4:00pm EDMONTON, Canada, Alberta
4:00pm REGINA, Canada, Saskatchewan
5:00pm WINNIPEG, Canada, Manitoba
7:00pm HALIFAX, Canada, Nova Scotia
7:30pm ST. JOHN’S, Canada, Newfoundland and Labrador

The meeting will be held virtually on ZOOM.
The link to join the meeting will be sent to CASL active members upon registration.
> REGISTER HERE <

ILCA 2025 Single Topic Workshop on Y90 and TACE in HCC and BTCs in Chicago
2025-06-06 | Chicago, IL, United States
The ILCA 2025 Single Topic Workshop on Y90 and TACE in HCC and BTCs will be held on June 6, 2025 in Chicago, IL. This workshop focuses on the evolving role of Y90 (Yttrium-90) and TACE (Transarterial Chemoembolization) in treating Hepatocellular Carcinoma (HCC) and Biliary Tract Cancers (BTCs).

Key Highlights:

Basic principles of embolization and immunotherapy in managing HCC and BTC.
Future perspectives on neoadjuvant and adjuvant treatments.
Current state of science for Y90 and TACE in HCC and BTC.
Hepatic artery infusion treatments.
Dynamic treatment landscape as patients migrate between treatments.
Combination treatments of locoregional and systemic therapies.
Ongoing clinical trials combining systemic and locoregional therapies.

The workshop aims to foster intimate conversations and real collaboration among experts in the field.
Don’t miss this opportunity to engage with leading experts, explore cutting-edge research, and collaborate on innovative treatment strategies.
Register now to secure your spot and be part of the future of cancer treatment!
Date: June 6, 2025
Location: Chicago, IL
Click Here To Learn More

Best of EASL: CASL Webinar Series
2025-05-15 19:30 - 20:30 (America/Toronto) | Online
Were you able to attend EASL 2025? If so, you know how many great sessions there were for discussion. If not, we are pleased to confirm that your CASL membership gives you exclusive, complimentary access to the Best of EASL: CASL Debrief Webinar.

The Best of EASL: CASL Debrief Webinar will be held online on Thursday, May 15th, 2025 7:30 PM EST. It is a concise, virtual session in which your Canadian colleagues will present some of the most interesting sessions from EASL 2025 on topics including liver tumors, viral hepatitis and more.
MODERATOR

Mayur Brahmania

SPEAKERS & TOPICS

Dana Kablawi, Alcohol, NASH & Metabolism
Daljeet Chahal, Cirrhosis & General Hepatology/Public Health & Transplantation
Aldo Montano-Loza, Immune-Mediated & Cholestatic Liver Diseases (Pediatrics)
Arndt Vogel, Liver Tumors
Scott Fung, Viral Hepatitis

Please click here to complete your complimentary registration. Prior to the meeting, you will receive the link to attend the webinar.

Global Hepatitis Summit 2025
2025-03-18 08:00 - 2025-03-21 17:00 UTC
The Global Hepatitis Summit 2025 will take place from March 18 to 21, 2025, at the Westin Bonaventure Hotel & Suites in Los Angeles, USA. This event, marking the 19th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD), will gather leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in hepatitis research, prevention, diagnosis, treatment, and elimination.

The summit will feature a comprehensive program with plenary sessions, parallel tracks, and symposia covering various aspects of viral hepatitis, including basic-translational science, clinical science, and public health. Attendees can expect to engage with cutting-edge research, innovative therapies, and public health strategies aimed at combating hepatitis B, C, and D.
For more information, visit the official Global Hepatitis Summit website.

North American Viral Hepatitis Elimination Summit
2025-03-18 08:00 - 17:00 UTC
The North American Viral Hepatitis Elimination Summit is a collaborative event organized by the American Association for the Study of Liver Diseases (AASLD), the Canadian Association for the Study of the Liver (CASL), and the Asociación Mexicana de Hepatología (AMH). This summit aims to foster collaboration, exchange ideas, and enhance knowledge translation among healthcare professionals across North America.
The summit will feature presentations and workshops led by public health and medical experts, focusing on strategies for viral hepatitis prevention, screening, diagnosis, and treatment. Attendees will learn about the latest innovations and how they can be applied to achieve the goal of viral hepatitis elimination and reduce liver complications, including liver cancer.
For more details, visit the official summit page.

Joint CDDW™-CLM Conference 2025
2025-02-28 - 2025-03-02 | Quebec City
The Joint CDDW™-CLM Conference 2025 is the premier meeting for all members of the Canadian gastroenterology and hepatology communities, including trainees, nurses, and researchers with an interest in liver and gastroenterology. We are delighted to invite you to the Joint 2025 Canadian Digestive Diseases Week™ and Canadian Liver Meeting Conference, taking place from February 28 to March 2, 2025, in Québec City, Quebec. This conference is a collaborative effort between the Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver, along with their affiliates: the Canadian Network on Hepatitis C, Canadian NASH Network, Canadian Association of Hepatology Nurses, and TRIANGLE.

CASL Educational Webinar Series: Hepatic Encephalopathy
2024-12-11 20:00 - 21:00 (America/Toronto) | Online
We are thrilled to invite you to an exclusive webinar on Hepatic Encephalopathy (HE), hosted by CASL with the generous support of Lupin. This session will feature leading experts discussing the latest advancements in diagnosing, managing, and treating HE. Register here to join.
Title: CASL Educational Webinar Series: Hepatic Encephalopathy
Date: Wednesday, December 11 at 8:00 pm ET
Format: Zoom webinar
Moderator: Chris Rose
Speakers:

Stephen Congly, Canada
Debbie Shawcross, UK

Schedule:
8:00 – 8:05 pm – Introduction – Chris Rose
8:05 – 8:25 pm – Presentation #1 – HE management review & Post-TIPS HE Management – Stephen Congly
8:25 – 8:45 pm – Presentation #2 – The Role of Infection in HE – Debbie Shawcross
8:45 – 9:00 pm – Q&A and Panel Discussion

Supported by unrestricted educational grant from:

REGISTER HERE

SHINE - Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies
2024-11-28 18:00 - 19:30 (America/Vancouver) | Online
You are cordially invited to SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies. A multidisciplinary virtual case-based discussion comprised of leading experts across Western Canada.
Thurs Nov 28 2024, 6-730 PST | 7-8:30 MST | 8-9:30 CST

Panelists

Dr Michael Bleszynski, HPB Surgeon at Vancouver General Hospital – Vancouver
Dr Mayur Brahmania, Hepatologist at University of Calgary and CASL’s Education Committee Co-Chair – Calgary
Dr Howard Lim, Medical Oncologist at BC Cancer Agency – Vancouver
Dr Dave Liu, Interventional Radiologist at University of British Columbia – Vancouver
Dr Maged Nashed, Radiation Oncologist at University of Manitoba – Winnipeg
Dr Jennifer Spratlin, Medical Oncologist at Cross Cancer Institute – Edmonton
Dr Vincent Tam, Medical Oncologist at Tom Baker Cancer Centre – Calgary

Objectives

Understand the current treatment landscape of intermediate HCC.
Analyze the emerging role of systemic therapies in TACE/TARE-eligible intermediate HCC.
Discuss the use of systemic therapy prior to liver transplant for intermediate stage HCC
patients.
Examine future directions and emerging therapies/treatment strategies in intermediate HCC.

Please RSVP here: https://forms.office.com/e/7qf5GTXZXu

The 75th Liver Meeting | AASLD
2024-11-15 - 2024-11-19
The 75th Liver Meeting is a global gathering you won’t want to miss! This is your opportunity to engage with other international partners dedicated to advancing liver health at #TLM24, Nov. 15-19 in San Diego! For over seven decades, this gathering has been the premier event for hepatology professionals worldwide to collaborate and share cutting-edge expertise. It’s not too late to register: https://www.aasld.org/the-liver-meeting

CASL Single Topic Conference on HCC
2024-10-19 14:15 - 2024-10-20 16:30 UTC | Hilton Toronto, 145 Richmond Street West, Toronto, Ontario, Canada
CASL is pleased to announce the Canadian Association for the Study of the Liver (CASL) Single Topic Conference on HCC. This prestigious event, dedicated to the exploration of advancements in liver cancer research and treatment, will be held in conjunction with the International Liver Cancer Association (ILCA) at the Hilton Toronto – 145 Richmond Street West in Toronto on October 19th and 20th, 2024.
More information on the program, registration and other details are available on the conference website.

ILCA 2024 Annual Conference
2024-10-18 11:00 - 2024-10-19 17:00 (America/Halifax) | Hilton Toronto, 145 Richmond Street West, Toronto, Ontario, Canada
The 18th edition of the ILCA Annual Conference will be held in conjunction with the Canadian Association for the Study of the Liver (CASL) Single Topic Conference on HCC on 17-19 October in Toronto, Canada, promising yet another enriching and impactful gathering for the liver cancer community.
Connect with inspiring liver cancer specialists through exceptional education and pioneering insights.
Join us in Toronto to unite minds and transform the landscape of liver cancer treatment and care.

Canadian Multidisciplinary Hepatobiliary Cancer Conference
2024-10-04 - 2024-10-05 | Toronto, Toronto, Canada
The 3rd CANADIAN MULTIDISCIPLINARY HEPATOBILIARY CANCER CONFERENCE (CMHCC) is taking place on Friday October 4 and Saturday October 5th, 2024 at the Omni King Edward Hotel in Toronto, Ontario, Canada.

This informative conference provides a unique opportunity for attendees to participate in presentations from international experts in the ﬁeld of Multidisciplinary Hepatobiliary Cancer. The scope of this meeting will highlight both recent research ﬁndings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of patients.
For more information, please visit CMHCC 2024 website.

Conference on Liver Disease in Africa (COLDA) 2024
2024-09-19 - 2024-09-21 | Cairo, Egypt
Co-organized by SOLDA and Academic Medical Education in close collaboration with regional societies, COLDA 2024 aims at empowering healthcare professionals (HCPs) to diagnose, prevent, treat, and achieve a cure for liver diseases for the benefit of patients in Africa.

This being the 7th COLDA, we continue to cultivate a platform that provides a unique opportunity for clinicians, researchers, policymakers, industry representatives, and other healthcare professionals in the African region. Together with support from an international community of experts, they will exchange knowledge on the latest developments and achievements in the management of viral hepatitis and liver disease with a special focus on the African context.
We aspire to provide you with a highly scientific and educational abstract-driven conference consisting of keynote speeches, state-of-the-art lectures, oral and poster abstract presentations, roundtable discussions, and debates with ample time for discussion.
We are certain that the conference will act as a catalyst for translating science into clinical practice while promoting medical education in the field of hepatology and setting up collaborations within the African region. Everyone will have an exceptional opportunity to share and acquire knowledge, and experience a wide spectrum of topics related to liver disease.

Advancing DEI in Transplantation: A Global Perspective
2024-09-13 - 2024-09-14
Join us for the inaugural Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective conference, hosted by the Ajmera Transplant Center in Toronto, September 13 and 14. This groundbreaking event brings together International Transplant Leaders, clinicians, surgeons, nurses, researchers, policy makers, and representatives from academic and community-based organizations.

Key Highlights:

Understanding DEI Challenges: Explore the critical challenges faced by transplant providers and patients in achieving Diversity, Equity, and Inclusion (DEI) across organ groups.
Patient-Centric Approach: Our focus centers on patients and caregivers, ensuring their voices are heard and their needs addressed.
Notable Speakers:

Nancy Ascher: A renowned transplant surgeon and advocate for equity in healthcare.
Norah Terrault: An expert in liver transplantation and a champion for diversity and inclusion.

Abstract Submission Open! Submit your abstract for poster presentation at the conference. Abstract submission deadline: May 1, 2024.
Don’t miss this unique opportunity to be part of a global dialogue on advancing DEI in transplantation. Learn more and register at deiintransplant.com.

2024 International HBV Meeting
2024-09-11 - 2024-09-15 | Chicago, IL, United States
The 2024 International HBV Meeting is the preeminent global conference on Hepatitis B research set to take place September 11-15, 2024 in Chicago, USA. This event brings together scientists, physicians, and public health professionals from around the world who are at the forefront of Hepatitis B research.

Hear from the leading experts in the field of Hepatitis B research. Engage in high-level discussions on the latest advancements in HBV research. Connect with peers, mentors, and leaders in the field.
Join us for this exciting event! Registration for the 2024 International HBV Meeting is now open. Click here to register.

EASL Congress 2024
2024-06-05 - 2024-06-08 | Allianz MiCo, Milan, Italy, Allianz MiCo, Milan, Italy
Welcome to EASL Congress 2024, a gathering that unites the world of hepatology, taking place from 5-8 June 2024 in Milan, Italy, as well as online.

Bringing together over 7,000 professionals, including clinicians, researchers, allied health professionals, patient representatives, and industry professionals, the EASL Congress stands out as Europe’s largest event in this domain.
Four days of congress full of interactivity and hands-on learning sessions from world-class faculty. Excellent opportunities for the liver community to present their research, network and interact face-to-face with the greatest minds in hepatology.

Canadian Viral Hepatitis Elimination Day
2024-05-09 08:00 - 17:00 UTC | Ottawa, Canada
On Thursday, May 9, 2024, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada, CanHepC, CanHepB, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa.
#CanHepDay24 #HepCantWait
Thank you to our many members and allies who are helping amplify our call for the federal government, as well as each province and territory, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030.
FIVE FEDERAL ASKS
In 2016, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories, there are five key things the federal government can do now.
1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.
An updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan.
2. Testing: Update hepatitis C screening guidelines to be evidence-based, develop evidence-based screening guidelines for hepatitis B, and start offering free, voluntary STBBI testing and linkage to care for all immigrants and newcomers.
Canada’s hepatitis C screening guidelines recommend only screening people with certain risk factors, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis.
3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.
Hepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.
​
4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.
Hepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12, which have a vaccination rate of ~70%, missing the 90% WHO target.
5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.
In order to measure our progress in viral hepatitis elimination, we need reliable, fulsome data about how many people are affected.

Social Media Graphics for Sharing

These graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.

Click on the image to save it

Click on the image to save it

Innovations in SLD Think-Tank 2024
2024-05-03 - 2024-05-04
This 2-day program will provide an interactive platform for endocrinologists, gastroenterologist hepatologists, primary care physicians, and associated health care professionals (PAs, nurses) working in the field of SLD. Outmost goal is to allow knowledge exchange on MASLD beyond the hepatology arena and among all levels of expertise.

The new format will employ the Wilton Park style in which we intend to have panel discussions around hot topics in order to generate ideas and provide insights and recommendations:

Bridging the Diagnostics Gap
Prevention is the ‘Cure’ Hidden in Plain Sight
The Future of Treatments Now
Making Ready Our World Unready
Targeting Investments for Social and Economic Returns
the Role of Social Media in MASLD Education
Open Science Session on MASLD

Each of the topics will be introduced by a short lecture highlighting the issue and kick-starting the discussion. After a focused discussion among the panel members, the discussion is opened to the audience ensuring an informal and interactive setting to discuss audience-proposed topics.
Register for SLD Think-Tank 2024
In addition, the SLD Think-Tank will accept abstract submissions and look forward to inviting the key contributors to take part in the relevant panel discussions.
Abstract Deadline: Friday, 1 March 2024 at 23:59 CET
Abstract Submission Link: https://virology.eventsair.com/sld2024/abstracts

World Liver Awareness Day Webinar
2024-04-19 10:00 - 11:30 (Europe/Helsinki)
SOLDA is proud to present World Liver Awareness Day Webinar, a 90-minute webinar focusing on challenges and solutions for liver disease in Africa.
The 90-minute program takes place on World Liver Day – 19 April 2024 – and showcases presentations from leading experts from the five African regions. The scientific program focuses on regionally prevalent and emerging liver diseases and special emphasis will be placed on ensuring the voices of those with lived experiences will be heard.

10:00 AM CAT / SAST
WHA – Patient Advocacy Group | The “Lost Voice” of the Patient Community
Danjuma K. Adda, MPH, FIMS, Dip-IMS, World Hepatitis Alliance (WHA), Nigeria

10:10 AM CAT / SAST
Eastern Africa | Viral Hepatitis (Delivery of Care Models)
Mercy Nyakowa, MD National AIDS and STI Control Program (NASCOP), Ministry of Health, Kenya
Hailemichael Desalegn Mekonnen, MD, PhD, St. Paul’s Hospital Millennium Medical College, Ethiopia
Ponsiano Ocama, MBChB, MMed, PhD, FCP(ECSA), Makerere University College of Health Sciences, Uganda
10:20 AM CAT
Western Africa | Role of Prolifica in Viral Hepatitis (Implementation & Research)
Gibril Ndow, MD, PhD, Unit The Gambia at LSHTM, The Gambia
Alice Nanelin Guingané, MD, MPH, Bogodogo University Hospital Center / University of Montpellier, Burkina Faso / France
10:30 AM CAT / SAST
Central Africa | Vertical Transmission
Christian Tzeuton, MD, Douala Medical School / Société Camerounaise de Gastro-Entérologie, Cameroon
10:40 AM CAT / SAST
Southern Africa | Alcohol & Toxins
Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD, University of Cape Town, South Africa
Mark Sonderup, B Pharm, MBChB, FCP(SA), MMed, University of Cape Town, South Africa
Seadimo Gasennelwe-Gabakgore, MD, MPH, Ministry of Health and Wellness, Botswana
10:50 AM CAT / SAST
Northern Africa | HCC
Manal Hamdy El-Sayed, MD, PhD, Ain Shams University, Egypt
Ashraf Omar, MD, MSc, Cairo University, Egypt
Nabil Debzi, MD, Algerian Society of Hepatogastroenterology and Endoscopy / Mustapha Hospital Algiers, Algeria
11:00 AM CAT / SAST
Q&A
11:30 AM CAT / SAST
Closure of Webinar

Obesity Update Congress
2024-04-11 | InterContinental Toronto Centre, 225 Front Street West, Toronto, Ontario, M5V 2X3, Canada
The inaugural Obesity Update (OU) congress is taking place on Thursday, April 11, 2024, at the InterContinental Toronto Centre. Additional information about the congress can be found on the website at www.obesityupdate.ca.

Online Opioid Self-Assessment Program (SAP)
2024-03-15 - 2024-04-30
Improve your opioid prescribing skills with the Online Opioid SAP accredited by both the Royal College of Physicians and Surgeons of Canada and the College of Family Physicians of Canada. Engage with the latest Canadian Opioid Guideline through interactive case studies and personalized feedback. Funded by Health Canada and CGPA, this not-for-profit program is your gateway to evidence-based opioid management.
This course is accredited as Section 3 for specialists (3 credits/hour) and Mainpro+ for Family Physicians (1 credit/hour).
The Online Opioid SAP is easily accessible, highly interactive, and it uses assessment as a technique for knowledge exchange and guideline implementation. To facilitate active learning, various styles are employed, including videos, case presentations, and an assortment of question types to keep you engaged and apply it in practice.
Secure, confidential, and always seeking your feedback to improve healthcare practices. Join the Online Opioid SAP at https://opioidassessment.ca/ and elevate your clinical expertise today.

Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
2024-02-21 12:00 (America/Toronto) | Online
The Canadian Society of Palliative Care Physicians has partnered with the Pulmonary Hypertension Association of Canada to offer the webinar, Quality of Lift Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension, on Feb 21st.
Palliative Care ECHO Project to offer targeted webinars to all physicians who treat patients with life-limiting illness. These sessions are accredited, free and open to everyone.

Quality of Life Matters: Palliative Care Strategies for Individuals with Pulmonary Hypertension
WEDNESDAY, February 21, 2024TIME: 9 AM PT / 10 AM MT / 3 PM CT / 4 PM ET / 5 PM ATL / 5:30 PM NL
Hosted by the Canadian Society of Palliative Care Physicians (CSPCP) and Pulmonary Hypertension Association of Canada (PHA Canada)
Presenters:
Dr. David Christiansen, MD FRCPC
Associate Professor and Co-Section Head, Section of Respirology,
University of Manitoba
Dr. Kirsten Wentlandt, MD, CCFP(PC), FRCPC, PhD, MHSc
W. Gifford-Jones Professor in Pain Control and Palliative Care,
Head of the Division of Palliative Care, University of Toronto
Target Audience: Physicians from across Canada
Description:Explore palliative care strategies for individuals with pulmonary hypertension (PH). We’ll delve into the disease course, prognosis, and impact on quality of life for patients with PH. Additionally, we’ll examine the opportunities and challenges in providing palliative care to individuals facing this condition, highlighting unique aspects as it relates to palliative care interventions.
In this session, we will:

review disease course, quality of life and prognosis of pulmonary hypertension (PH).
review opportunities and challenges in providing palliative care to patients with PH.
discuss unique aspects of PH as it pertains to palliative care interventions.

ECHO sessions are free to attend and open to any person with an interest in the topic; however, the subject material is designed for physician audiences.
At the beginning of this session, the speaker(s) will present a case, which will be followed by a moderated and interactive discussion among participants.
The CSPCP Palliative Care Echo Sessions is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
CFPC members may claim 1 Mainpro+ Non-certified Group Learning credit
